BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 2 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,806 | -44.8% | 39,031 | +468.2% | 0.00% | – |
Q2 2023 | $14,150 | +48693.1% | 6,869 | -22.5% | 0.00% | -100.0% |
Q1 2023 | $29 | +1350.0% | 8,862 | +739.2% | 0.00% | – |
Q4 2022 | $2 | -100.0% | 1,056 | -81.0% | 0.00% | – |
Q2 2022 | $15,000 | +7.1% | 5,544 | +61.1% | 0.00% | – |
Q4 2021 | $14,000 | -68.9% | 3,442 | -70.8% | 0.00% | -100.0% |
Q1 2021 | $45,000 | +125.0% | 11,805 | +171.9% | 0.00% | 0.0% |
Q4 2020 | $20,000 | -95.0% | 4,342 | -81.6% | 0.00% | -75.0% |
Q3 2020 | $400,000 | +2566.7% | 23,632 | +1688.9% | 0.00% | +300.0% |
Q2 2020 | $15,000 | -72.2% | 1,321 | -88.7% | 0.00% | -66.7% |
Q1 2020 | $54,000 | +12.5% | 11,689 | +4.8% | 0.00% | -25.0% |
Q4 2019 | $48,000 | +2300.0% | 11,155 | +1640.2% | 0.00% | – |
Q3 2019 | $2,000 | -33.3% | 641 | -6.8% | 0.00% | – |
Q3 2018 | $3,000 | -40.0% | 688 | -50.4% | 0.00% | – |
Q2 2018 | $5,000 | +25.0% | 1,387 | +14.3% | 0.00% | – |
Q1 2018 | $4,000 | -33.3% | 1,214 | -19.3% | 0.00% | -100.0% |
Q4 2017 | $6,000 | -14.3% | 1,504 | -16.0% | 0.00% | 0.0% |
Q3 2017 | $7,000 | – | 1,791 | +59600.0% | 0.00% | – |
Q3 2016 | $0 | -100.0% | 3 | -99.7% | 0.00% | – |
Q1 2016 | $3,000 | +200.0% | 999 | +306.1% | 0.00% | – |
Q4 2015 | $1,000 | -66.7% | 246 | -79.8% | 0.00% | – |
Q3 2015 | $3,000 | +50.0% | 1,217 | +156.8% | 0.00% | – |
Q2 2015 | $2,000 | +100.0% | 474 | +273.2% | 0.00% | – |
Q1 2015 | $1,000 | – | 127 | – | 0.00% | – |
Q4 2014 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 242,850 | $923,000 | 0.13% |
ABNER HERRMAN & BROCK LLC | 241,500 | $918,000 | 0.13% |
Weaver Consulting Group | 48,881 | $186,000 | 0.10% |
Tibra Equities Europe Ltd | 87,000 | $331,000 | 0.10% |
Ikarian Capital, LLC | 293,200 | $1,115,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 60,238 | $229,000 | 0.03% |
Ergoteles LLC | 124,329 | $472,000 | 0.01% |
CFO4Life Group, LLC | 12,003 | $46,000 | 0.01% |
HighPoint Advisor Group LLC | 17,033 | $65,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 32,836 | $125,000 | 0.00% |